Tamara Fountain
CIK: 0001902243
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jun 17, 2026RXST
RxSight, Inc.
Award(A)Direct37K shares- - Jun 4, 2026SGHT
Sight Sciences, Inc.
Award(A)Direct28.3K shares- - Jun 5, 2025SGHT
Sight Sciences, Inc.
Award(A)Direct31K shares- - Jun 3, 2025RXST
RxSight, Inc.
Award(A)Direct10.8K shares- - Mar 12, 2025RXST
RxSight, Inc.
Sale(S)Direct7K shares at avg. $25.71$180K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 17, 2026 |  RXST RxSight, Inc. | Award(A) | 37,037 | - | $0 | Direct |
| Jun 4, 2026 |  SGHT Sight Sciences, Inc. | Award(A) | 28,261 | - | $0 | Direct |
| Jun 5, 2025 | SGHT Sight Sciences, Inc. | Award(A) | 30,952 | - | - | Direct |
| Jun 3, 2025 | RXST RxSight, Inc. | Award(A) | 10,752 | - | - | Direct |
| Mar 12, 2025 | RXST RxSight, Inc. | Sale(S) | 7,000 | $25.71 | $180,002 | Direct |
1-5 of 5 transactions
About Fountain Tamara
Fountain Tamara (SEC CIK 0001902243) files insider reports with the SEC as Director of RxSight, Inc. (RXST) and Director of Sight Sciences, Inc. (SGHT).
Signal8 holds 5 ownership filings by Fountain Tamara, all Form 4s, filed between Mar 13, 2025 and Jun 18, 2026. Those filings report 5 transactions, from Mar 12, 2025 to Jun 17, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Fountain Tamara's filings is in MENLO PARK, CA.
Recent filings by Fountain Tamara
- Jun 17, 2026: Grant or award of RXST shares (Form 4, code A).
- Jun 4, 2026: Grant or award of SGHT shares (Form 4, code A).
- Jun 5, 2025: Grant or award of SGHT shares (Form 4, code A).
- Jun 3, 2025: Grant or award of RXST shares (Form 4, code A).
- Mar 12, 2025: Open-market sale of RXST shares (Form 4, code S).
Other insiders filing for RxSight, Inc. (RXST)
- Weinberg Eric
- Wilterding Mark, Chief Financial Officer
- Kurtz Ronald M MD, Chief Medical Officer
- Goldshleger Ilya, Chief Operating Officer
- Mottiwala Aziz, President and CEO
- Warner Robert Keith, Director